The usefulness of the stereomicroscopic on-site evaluation of the EUS-guided tissue acquisition for the preoperative diagnosis in patients with resectable or borderline resectable pancreatic cancer

The usefulness of the stereomicroscopic on-site evaluation of the EUS-guided tissue acquisition for the preoperative diagnosis in patients with resectable or borderline resectable pancreatic cancer - The usefulness of the SOSE of the EUS-TA for the preoperative diagnosis in patients with PC

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000044023

Enrollment

Registered

2021-05-01

Start date

2021-05-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

resectable pancreatic cancer or borderline resectable pancreatic cancer

Interventions

procedure of the EUS-TA with SOSE

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) pancreatic tumor which are required EUS-TA for pathological diagnosis 2) patients whom suspected resectable or borderline resectable pancreatic cancer 3) adequate organ functions 4) providing written informed consent, and age =or >20

Exclusion criteria

Exclusion criteria: 1) patients in which iodine-containing contrast agent cannot be used due to drug allergies or renal dysfunction

Design outcomes

Primary

Measure	Time frame
the sensitivity of SVWC cutoff value in EUS-TA with SOSE	—

Countries

Japan

Contacts

Public ContactKosuke Okuwaki

Kitasato University School of Medicine Gastroenterology

kokuwaki@kitasato-u.ac.jp+81-42-778-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026